Penn Center for Innovation
August 25, 2022 |
Posted in School of Medicine, Startups
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
August 8, 2022 |
Posted in Startups, Success Story
Tumors within the heart affect thousands of patients around the world annually, but prior to the ŌNŌ system, open-heart surgery was the only way to remove them.